trending Market Intelligence /marketintelligence/en/news-insights/trending/6GD0p72SWWU2DLjPnJUB-Q2 content esgSubNav
In This List

NeuroMetrix prices $26.5M offering

Blog

Insight Weekly: US inflation soars; real estate faces slowdown; megadeals drive tech M&A

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Insight Weekly: Path to net-zero; US manufacturing momentum; China's lithium M&A frenzy


NeuroMetrix prices $26.5M offering

NeuroMetrix Inc. priced a public offering to raise $26.5 million in gross proceeds.

The offering was priced at 70 cents per common share, with each share sold with 1 warrant to purchase 1 common share. The warrants are exercisable at a price of 70 cents per common share immediately upon issuance and will expire five years after issuance.

NeuroMetrix will use about $19.45 million of the proceeds to redeem about 19,450 series D convertible preferred shares and retire about 23.5 million warrants to buy outstanding common stock. The company will use the remaining proceeds to fund the commercialization of Quell, its over-the-counter wearable device for relief of chronic pain, in the U.S. and for general corporate purposes.

The offering is expected to close Dec. 23, subject to customary closing conditions.

Rodman & Renshaw is the offering's exclusive placement agent.